骨骼氟中毒:一种少见病因,却可被救援性治疗?
本文报告一例50岁女性因长期吸入含二氟乙烷的键盘清洁剂导致骨骼氟中毒,表现为多次复发性低能量创伤骨折而影像学骨密度高,血清氟升高且非脱钙经髂骨活检证实骨软化。停用氟暴露后给予甲状旁腺激素类似物阿巴洛肽治疗,骨密度下降且氟水平降低。
要点
- 骨骼氟中毒由慢性氟暴露引起,可致骨组织异常矿化、脆性增加、骨折和骨赘形成。
- 除避免氟来源外尚无确立治疗,氟可在暴露停止后于骨中存留数十年。
- 阿巴洛肽可能诱导矿化骨转换以替换骨软化骨,本例治疗后骨密度和氟水平均降低。
核心结论
- 由于氟在骨中半衰期长,骨骼氟中毒可在氟暴露停止很久后仍引起骨折。
- 获批用于骨质疏松的合成代谢治疗如阿巴洛肽,可能诱导矿化骨转换以替换骨骼氟中毒特征性的矿化不良骨软化骨,从而降低骨折风险。
研究设计与样本
- 个案报告:一名50岁女性,表现为多次复发性低能量创伤骨折而影像学骨密度高,血清氟升高,非脱钙经髂骨活检证实骨软化,自述多年间断「吸入」含二氟乙烷的键盘清洁剂。
- 停用氟暴露后,评估给予甲状旁腺激素类似物阿巴洛肽,希望增加骨重塑并减少骨骼氟负荷。
主要发现
- 患者为50岁女性,表现为多次复发性低能量创伤骨折,影像学骨密度高。
- 血清氟升高,非脱钙经髂骨活检证实骨软化。
- 患者自述多年间断「吸入」含二氟乙烷的键盘清洁剂。
- 阿巴洛肽治疗后,患者骨密度下降,氟水平降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Skeletal fluorosis (SF) results from chronic exposure to fluoride (F-) causing excessive aberrantly mineralized brittle bone tissue, fractures, and exostoses. There is no established treatment other than avoiding the source of F-. Still, excess F- can persist in bone for decades after exposure ceases. CASE PRESENTATION: A 50-year-old woman presented with multiple, recurrent, low AQ2 trauma fractures yet high radiologic bone mineral density. Serum F- was elevated, and osteomalacia was documented by non-decalcified transiliac biopsy. She reported intermittently "huffing" a keyboard cleaner containing F- (difluoroethane) for years. Following cessation of her F- exposure, we evaluated the administration of the parathyroid hormone analog, abaloparatide, hoping to increase bone remodeling and diminish her skeletal F- burden. CONCLUSION: Due to the prolonged half-life of F- in bone, SF can cause fracturing long after F- exposure stops. Anabolic therapy approved for osteoporosis, such as abaloparatide, may induce mineralized bone turnover to replace the poorly mineralized osteomalacic bone characteristic of SF and thereby diminish fracture risk. Following abaloparatide treatment for our patient, there was a decrease in bone density as well as a reduction in F- levels.
引用
- Shariff JRR, Swe KM, Binkley N, et al. Skeletal fluorosis: an uncommon cause, yet a rescue treatment? Osteoporos Int. 2024. PMID: 38847810. doi:10.1007/s00198-024-07137-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。